company
as of 2026-07-01German Federal Ministry of Education and Research
at a glance
10 trials sponsored · 18 assets in the graph
Synthesized from structured facts only — each point cited above.
Financials
SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).
Pipeline
18 assets
AmisulprideAripiprazoleFlupentixolHaloperidolOlanzapineQuetiapineRisperidoneActive TDCSAdaptive working memory trainingBasic Cognitive TrainingCognitive Behavioral Therapy (CBT)Complex Problem Solving TrainingSupportive Counselling (SC)Supportive managementantipsychotics vs. Lorazepam (Drugs)maintained antipsychotic treatment vs. stepwise drug discontinuationpeer supportpsychotherapeutic STEM modules
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
drugsmall molecule
Aripiprazole
drugsmall molecule
Flupentixol
drugsmall molecule
Haloperidol
drugsmall molecule
Olanzapine
drugsmall molecule
Quetiapine
drugsmall molecule
Risperidone
drugsmall molecule
Active TDCS
drugOTHER